Results 141 to 150 of about 2,878 (233)

[Efficacy of chewing gum in post-cesarean ileus: A randomized clinical trial]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Cortes-Cernas VI   +9 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo   +7 more
wiley   +1 more source

[Annular Pancreas in Adults. A Case Report]. [PDF]

open access: yesActa Gastroenterol Latinoam
Marulanda Fernández H   +2 more
europepmc   +1 more source

COMPARAÇÃO ENTRE O USO ASSOCIADO DE DEXAMETASONA, ONDANSETRONA E METOCLOPRAMIDA NA PREVENÇÃO DE NÁUSEAS E VÔMITOS EM PACIENTES SUBMETIDOS À COLECISTECTOMIA VIDEOLAPAROSCÓPICA: ENSAIO CLÍNICO RANDOMIZADO

open access: bronze, 2022
Júlia Costa Justo   +5 more
openalex   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

[Prevalence of Rumination Syndrome: Experience in Three Countries of the Working Group on Brain-Gut Disorders of the Latin American Society of Pediatric Gastroenterology, Hepatology and Nutrition (LASPGHAN)]. [PDF]

open access: yesActa Gastroenterol Latinoam
Velasco-Benítez CA   +6 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy